| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
803 |
| issn |
0306-5251
1365-2125 |
| issueIdentifier |
6 |
| pageRange |
801-803 |
| publicationName |
British Journal of Clinical Pharmacology |
| startingPage |
801 |
| bibliographicCitation |
Ritter JM. TP receptor antagonists (TXRAs): expensive irrelevance or wonder drugs strangled at birth? Brit J Clinical Pharma. 2011 May 12;71(6):801–3. doi: 10.1111/j.1365-2125.2011.03985.x. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_013c3cde029ffb88469b6c216cd6812c |
| date |
2011-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/21564159
https://pubmed.ncbi.nlm.nih.gov/PMC3099365
https://doi.org/10.1111/j.1365-2125.2011.03985.x |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1743
https://portal.issn.org/resource/ISSN/0306-5251
https://portal.issn.org/resource/ISSN/1365-2125 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
TP receptor antagonists (TXRAs): expensive irrelevance or wonder drugs strangled at birth? |
| discusses |
http://id.nlm.nih.gov/mesh/M0026518
http://id.nlm.nih.gov/mesh/M0001864 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D017482Q000037
http://id.nlm.nih.gov/mesh/D001241Q000494
http://id.nlm.nih.gov/mesh/D015195 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D017482Q000627
http://id.nlm.nih.gov/mesh/D016032 |